Imiglucerase |
Cerezyme |
Image:Imiglucerase.png Imiglucerase Systematic (IUPAC) name Human Beta-glucocerebrosidase Identifiers CAS number 143003-46-7 ATC code A16AB02 PubChem ? DrugBank BTD00026 Chemical data Formula C2532H3854N672O711S16 Mol. weight 55597.4 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life 3.6-10.4 min Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Imiglucerase is a recomb ...
Wikipedia - [full article]
Imiglucerase Clinical Trials
- Multicenter Open-Label Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
ClinicalTrials.gov Identifier: NCT00478647 - Recruiting
Gaucher Disease, Type 1
- A Multicenter, Randomized, Double-Blind, Parallel-Group Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease
ClinicalTrials.gov Identifier: NCT00553631 - Not yet recruiting
Gaucher Disease, Type 1

Not Signed In -


